 Joseph Kay
Concepts (250)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart Defects, Congenital | 20 | 2022 | 703 | 1.830 |
Why?
| | Transposition of Great Vessels | 7 | 2023 | 28 | 1.280 |
Why?
| | Tetralogy of Fallot | 9 | 2018 | 79 | 1.010 |
Why?
| | Catheter Ablation | 8 | 2019 | 286 | 0.660 |
Why?
| | Atrial Fibrillation | 6 | 2022 | 338 | 0.630 |
Why?
| | Cardiac Catheterization | 7 | 2020 | 541 | 0.600 |
Why?
| | Fontan Procedure | 4 | 2019 | 154 | 0.570 |
Why?
| | Tachycardia, Ventricular | 5 | 2019 | 151 | 0.570 |
Why?
| | Pacemaker, Artificial | 3 | 2020 | 105 | 0.570 |
Why?
| | Stents | 4 | 2018 | 456 | 0.560 |
Why?
| | Cardiology | 2 | 2020 | 272 | 0.540 |
Why?
| | Pulmonary Valve | 5 | 2018 | 99 | 0.530 |
Why?
| | Aortic Coarctation | 2 | 2023 | 57 | 0.520 |
Why?
| | Heart Valve Diseases | 3 | 2020 | 135 | 0.430 |
Why?
| | Heart Septal Defects, Atrial | 3 | 2013 | 50 | 0.430 |
Why?
| | Ventricular Dysfunction, Right | 3 | 2023 | 228 | 0.380 |
Why?
| | Arterial Switch Operation | 2 | 2022 | 5 | 0.360 |
Why?
| | Heart Valve Prosthesis Implantation | 4 | 2018 | 189 | 0.360 |
Why?
| | Sick Sinus Syndrome | 1 | 2009 | 2 | 0.350 |
Why?
| | Electrophysiologic Techniques, Cardiac | 7 | 2019 | 72 | 0.340 |
Why?
| | Thromboembolism | 2 | 2022 | 99 | 0.340 |
Why?
| | Arrhythmias, Cardiac | 4 | 2019 | 277 | 0.330 |
Why?
| | Antiphospholipid Syndrome | 1 | 2009 | 29 | 0.330 |
Why?
| | Ultrasonography, Interventional | 2 | 2013 | 155 | 0.330 |
Why?
| | Bradycardia | 1 | 2009 | 49 | 0.330 |
Why?
| | Hypoplastic Left Heart Syndrome | 2 | 2009 | 112 | 0.330 |
Why?
| | Adult | 40 | 2023 | 31510 | 0.330 |
Why?
| | Catheterization | 2 | 2010 | 163 | 0.320 |
Why?
| | Coronary Angiography | 4 | 2013 | 311 | 0.320 |
Why?
| | Aneurysm, False | 1 | 2008 | 46 | 0.310 |
Why?
| | Atrial Flutter | 3 | 2017 | 24 | 0.290 |
Why?
| | Treatment Outcome | 20 | 2022 | 9342 | 0.290 |
Why?
| | Follow-Up Studies | 13 | 2022 | 4596 | 0.290 |
Why?
| | Aortic Aneurysm, Thoracic | 1 | 2008 | 121 | 0.280 |
Why?
| | Cardiac Surgical Procedures | 4 | 2018 | 461 | 0.280 |
Why?
| | Tachycardia, Atrioventricular Nodal Reentry | 3 | 2016 | 27 | 0.260 |
Why?
| | Forecasting | 2 | 2017 | 353 | 0.260 |
Why?
| | Heart Failure | 3 | 2023 | 1968 | 0.250 |
Why?
| | Pulmonary Valve Insufficiency | 3 | 2016 | 36 | 0.240 |
Why?
| | Cryosurgery | 2 | 2018 | 54 | 0.240 |
Why?
| | Heart Rate | 3 | 2019 | 729 | 0.240 |
Why?
| | Tricuspid Valve Insufficiency | 1 | 2023 | 18 | 0.230 |
Why?
| | Risk Assessment | 5 | 2017 | 3057 | 0.230 |
Why?
| | Retrospective Studies | 21 | 2023 | 12975 | 0.230 |
Why?
| | Electrocardiography | 7 | 2017 | 556 | 0.230 |
Why?
| | Echocardiography, Transesophageal | 3 | 2010 | 89 | 0.230 |
Why?
| | Male | 38 | 2023 | 57800 | 0.230 |
Why?
| | Humans | 54 | 2023 | 118969 | 0.220 |
Why?
| | Prostheses and Implants | 1 | 2004 | 141 | 0.220 |
Why?
| | Female | 36 | 2023 | 61564 | 0.210 |
Why?
| | Anticoagulants | 3 | 2022 | 559 | 0.210 |
Why?
| | Carcinoma, Hepatocellular | 1 | 2023 | 227 | 0.200 |
Why?
| | Myocardial Infarction | 1 | 2009 | 968 | 0.200 |
Why?
| | Continuity of Patient Care | 3 | 2020 | 265 | 0.200 |
Why?
| | Young Adult | 16 | 2023 | 10793 | 0.190 |
Why?
| | Heart Septal Defects, Ventricular | 2 | 2019 | 43 | 0.190 |
Why?
| | American Heart Association | 2 | 2017 | 270 | 0.190 |
Why?
| | Data Collection | 2 | 2013 | 658 | 0.190 |
Why?
| | Postoperative Complications | 3 | 2019 | 2235 | 0.180 |
Why?
| | Radiology, Interventional | 1 | 2020 | 28 | 0.180 |
Why?
| | Cardiologists | 1 | 2020 | 40 | 0.180 |
Why?
| | Liver Neoplasms | 1 | 2023 | 527 | 0.170 |
Why?
| | Ventricular Outflow Obstruction | 1 | 2018 | 36 | 0.160 |
Why?
| | Marfan Syndrome | 2 | 2019 | 42 | 0.160 |
Why?
| | Ventricular Dysfunction, Left | 2 | 2013 | 374 | 0.160 |
Why?
| | Aortic Valve Insufficiency | 2 | 2015 | 42 | 0.160 |
Why?
| | Hypertension | 2 | 2023 | 1203 | 0.160 |
Why?
| | Patient Education as Topic | 2 | 2013 | 699 | 0.160 |
Why?
| | Time Factors | 7 | 2019 | 6412 | 0.160 |
Why?
| | Preoperative Care | 2 | 2018 | 332 | 0.160 |
Why?
| | Middle Aged | 18 | 2023 | 27617 | 0.150 |
Why?
| | Heart Transplantation | 1 | 2023 | 671 | 0.150 |
Why?
| | Tachycardia, Reciprocating | 1 | 2017 | 6 | 0.150 |
Why?
| | Abnormalities, Multiple | 1 | 2019 | 181 | 0.150 |
Why?
| | Tachycardia, Supraventricular | 1 | 2017 | 40 | 0.150 |
Why?
| | Heart Ventricles | 2 | 2020 | 727 | 0.150 |
Why?
| | Heart Valve Prosthesis | 1 | 2018 | 125 | 0.150 |
Why?
| | Hepatic Veins | 2 | 2016 | 31 | 0.150 |
Why?
| | Survivors | 1 | 2020 | 418 | 0.150 |
Why?
| | Adolescent | 13 | 2023 | 18479 | 0.140 |
Why?
| | Aorta | 2 | 2023 | 367 | 0.140 |
Why?
| | Aortic Valve Stenosis | 1 | 2020 | 295 | 0.140 |
Why?
| | Liver Transplantation | 1 | 2023 | 847 | 0.140 |
Why?
| | Venous Thromboembolism | 1 | 2019 | 234 | 0.140 |
Why?
| | Tachycardia | 1 | 2016 | 48 | 0.140 |
Why?
| | Education, Medical, Graduate | 1 | 2020 | 399 | 0.140 |
Why?
| | Prevalence | 7 | 2019 | 2326 | 0.140 |
Why?
| | Aortic Valve | 2 | 2020 | 401 | 0.130 |
Why?
| | Biomedical Research | 2 | 2013 | 612 | 0.130 |
Why?
| | Vectorcardiography | 1 | 2014 | 5 | 0.130 |
Why?
| | Pulmonary Veins | 1 | 2016 | 84 | 0.130 |
Why?
| | Radiography, Interventional | 2 | 2013 | 113 | 0.120 |
Why?
| | Tricuspid Valve | 1 | 2014 | 23 | 0.120 |
Why?
| | Glutamate Carboxypeptidase II | 1 | 2013 | 4 | 0.120 |
Why?
| | Cardiac Resynchronization Therapy Devices | 1 | 2013 | 14 | 0.120 |
Why?
| | Heart-Assist Devices | 1 | 2020 | 485 | 0.120 |
Why?
| | Tomography, X-Ray Computed | 4 | 2015 | 2436 | 0.120 |
Why?
| | Hypoxia | 1 | 2020 | 963 | 0.120 |
Why?
| | Antigens, Surface | 1 | 2013 | 156 | 0.120 |
Why?
| | Eisenmenger Complex | 1 | 2013 | 10 | 0.120 |
Why?
| | Disease Management | 1 | 2017 | 571 | 0.110 |
Why?
| | Cardiac Care Facilities | 1 | 2013 | 14 | 0.110 |
Why?
| | Heart Atria | 1 | 2014 | 112 | 0.110 |
Why?
| | Portal Vein | 1 | 2014 | 90 | 0.110 |
Why?
| | Electrodes, Implanted | 1 | 2013 | 97 | 0.110 |
Why?
| | Microbubbles | 1 | 2013 | 38 | 0.110 |
Why?
| | Prosthesis Design | 3 | 2018 | 285 | 0.110 |
Why?
| | Diastole | 1 | 2013 | 145 | 0.110 |
Why?
| | Predictive Value of Tests | 6 | 2014 | 1868 | 0.110 |
Why?
| | Sodium Chloride | 1 | 2013 | 144 | 0.110 |
Why?
| | Severity of Illness Index | 4 | 2019 | 2674 | 0.100 |
Why?
| | Aortic Diseases | 1 | 2012 | 94 | 0.100 |
Why?
| | Age Factors | 5 | 2017 | 2995 | 0.100 |
Why?
| | Therapy, Computer-Assisted | 1 | 2011 | 60 | 0.100 |
Why?
| | Mental Disorders | 1 | 2019 | 939 | 0.100 |
Why?
| | Exercise Test | 3 | 2023 | 551 | 0.100 |
Why?
| | Radiographic Image Interpretation, Computer-Assisted | 1 | 2011 | 109 | 0.100 |
Why?
| | Angioplasty, Balloon | 1 | 2011 | 88 | 0.100 |
Why?
| | Heart Diseases | 3 | 2013 | 341 | 0.090 |
Why?
| | Imaging, Three-Dimensional | 2 | 2011 | 499 | 0.090 |
Why?
| | Pregnancy Complications, Cardiovascular | 1 | 2011 | 70 | 0.090 |
Why?
| | Echocardiography | 1 | 2013 | 556 | 0.090 |
Why?
| | Internship and Residency | 1 | 2020 | 1001 | 0.090 |
Why?
| | Prospective Studies | 7 | 2018 | 6471 | 0.090 |
Why?
| | Patient Participation | 1 | 2013 | 369 | 0.090 |
Why?
| | Child | 10 | 2023 | 19129 | 0.090 |
Why?
| | Cell Movement | 1 | 2013 | 896 | 0.090 |
Why?
| | Risk Factors | 7 | 2019 | 8999 | 0.080 |
Why?
| | Chest Pain | 1 | 2009 | 84 | 0.080 |
Why?
| | Anti-Arrhythmia Agents | 2 | 2019 | 113 | 0.080 |
Why?
| | Pregnancy Outcome | 1 | 2011 | 349 | 0.080 |
Why?
| | Equipment Failure | 1 | 2009 | 114 | 0.080 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2013 | 1167 | 0.080 |
Why?
| | Child, Preschool | 6 | 2019 | 9491 | 0.080 |
Why?
| | Cross-Sectional Studies | 6 | 2013 | 4552 | 0.080 |
Why?
| | Multicenter Studies as Topic | 1 | 2008 | 253 | 0.080 |
Why?
| | Aged | 7 | 2020 | 19656 | 0.070 |
Why?
| | Fosinopril | 1 | 2006 | 1 | 0.070 |
Why?
| | Cardiopulmonary Bypass | 1 | 2008 | 203 | 0.070 |
Why?
| | Pulmonary Artery | 1 | 2011 | 1063 | 0.070 |
Why?
| | United States | 6 | 2018 | 12554 | 0.070 |
Why?
| | Physicians | 1 | 2013 | 793 | 0.070 |
Why?
| | Angiotensin-Converting Enzyme Inhibitors | 1 | 2006 | 195 | 0.060 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2013 | 1185 | 0.060 |
Why?
| | Altitude | 1 | 2008 | 422 | 0.060 |
Why?
| | Evidence-Based Medicine | 1 | 2008 | 693 | 0.060 |
Why?
| | Aged, 80 and over | 3 | 2019 | 6561 | 0.060 |
Why?
| | International Normalized Ratio | 1 | 2022 | 45 | 0.050 |
Why?
| | Vitamin K | 1 | 2022 | 44 | 0.050 |
Why?
| | Pulmonary Atresia | 2 | 2012 | 7 | 0.050 |
Why?
| | Health Services Accessibility | 1 | 2007 | 781 | 0.050 |
Why?
| | Hemodynamics | 2 | 2018 | 1004 | 0.050 |
Why?
| | Cohort Studies | 2 | 2022 | 5115 | 0.050 |
Why?
| | Arteries | 1 | 2022 | 250 | 0.050 |
Why?
| | Exercise | 1 | 2011 | 1657 | 0.050 |
Why?
| | Multivariate Analysis | 2 | 2017 | 1474 | 0.050 |
Why?
| | Fibrinolytic Agents | 1 | 2022 | 237 | 0.050 |
Why?
| | Gonadal Dysgenesis | 1 | 2019 | 9 | 0.040 |
Why?
| | Neoplasms | 1 | 2013 | 2179 | 0.040 |
Why?
| | Philadelphia | 1 | 2019 | 47 | 0.040 |
Why?
| | DiGeorge Syndrome | 1 | 2019 | 21 | 0.040 |
Why?
| | Sensitivity and Specificity | 2 | 2014 | 1795 | 0.040 |
Why?
| | Colorado | 2 | 2019 | 4196 | 0.040 |
Why?
| | Prader-Willi Syndrome | 1 | 2019 | 27 | 0.040 |
Why?
| | Ultrasonography | 2 | 2014 | 716 | 0.040 |
Why?
| | Attention Deficit and Disruptive Behavior Disorders | 1 | 2019 | 56 | 0.040 |
Why?
| | Fragile X Syndrome | 1 | 2019 | 80 | 0.040 |
Why?
| | Mood Disorders | 1 | 2019 | 119 | 0.040 |
Why?
| | Hemorrhage | 1 | 2022 | 623 | 0.040 |
Why?
| | Quebec | 1 | 2017 | 5 | 0.040 |
Why?
| | Consensus | 1 | 2020 | 534 | 0.040 |
Why?
| | Perioperative Period | 1 | 2017 | 51 | 0.040 |
Why?
| | Extracorporeal Membrane Oxygenation | 1 | 2020 | 240 | 0.040 |
Why?
| | Heart Conduction System | 1 | 2017 | 81 | 0.040 |
Why?
| | Electrocardiography, Ambulatory | 1 | 2017 | 53 | 0.040 |
Why?
| | Reoperation | 1 | 2019 | 557 | 0.040 |
Why?
| | Recurrence | 1 | 2019 | 975 | 0.040 |
Why?
| | Blood Pressure | 1 | 2023 | 1664 | 0.030 |
Why?
| | Anxiety Disorders | 1 | 2019 | 309 | 0.030 |
Why?
| | Action Potentials | 1 | 2019 | 420 | 0.030 |
Why?
| | Electric Stimulation | 1 | 2016 | 268 | 0.030 |
Why?
| | ROC Curve | 1 | 2016 | 473 | 0.030 |
Why?
| | Patient Outcome Assessment | 1 | 2016 | 122 | 0.030 |
Why?
| | Liver Diseases | 1 | 2017 | 282 | 0.030 |
Why?
| | Angiography | 1 | 2015 | 185 | 0.030 |
Why?
| | Magnetic Resonance Angiography | 1 | 2016 | 210 | 0.030 |
Why?
| | Recovery of Function | 1 | 2018 | 604 | 0.030 |
Why?
| | Down Syndrome | 1 | 2019 | 356 | 0.030 |
Why?
| | Odds Ratio | 1 | 2017 | 996 | 0.030 |
Why?
| | Health Surveys | 1 | 2016 | 454 | 0.030 |
Why?
| | Cost of Illness | 1 | 2016 | 258 | 0.030 |
Why?
| | Curriculum | 1 | 2020 | 910 | 0.030 |
Why?
| | Prostatectomy | 1 | 2013 | 100 | 0.030 |
Why?
| | Phlebography | 1 | 2013 | 40 | 0.030 |
Why?
| | Sinus of Valsalva | 1 | 2012 | 9 | 0.030 |
Why?
| | Kidney Diseases | 1 | 2017 | 439 | 0.030 |
Why?
| | Clinical Competence | 1 | 2020 | 951 | 0.030 |
Why?
| | Dilatation, Pathologic | 1 | 2012 | 56 | 0.030 |
Why?
| | Neoplasm Grading | 1 | 2013 | 258 | 0.030 |
Why?
| | Surgery, Computer-Assisted | 1 | 2013 | 69 | 0.030 |
Why?
| | Microscopy, Confocal | 1 | 2013 | 314 | 0.030 |
Why?
| | Echocardiography, Doppler | 1 | 2013 | 95 | 0.030 |
Why?
| | Prosthesis Implantation | 1 | 2013 | 141 | 0.030 |
Why?
| | Congresses as Topic | 1 | 2013 | 204 | 0.030 |
Why?
| | Fluoroscopy | 1 | 2013 | 146 | 0.030 |
Why?
| | Logistic Models | 1 | 2017 | 1901 | 0.030 |
Why?
| | RNA Interference | 1 | 2013 | 460 | 0.030 |
Why?
| | Neoplasm Metastasis | 1 | 2013 | 544 | 0.030 |
Why?
| | Cineangiography | 1 | 2011 | 17 | 0.030 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2013 | 982 | 0.020 |
Why?
| | Kaplan-Meier Estimate | 1 | 2013 | 842 | 0.020 |
Why?
| | Constriction, Pathologic | 1 | 2011 | 203 | 0.020 |
Why?
| | Feasibility Studies | 1 | 2013 | 749 | 0.020 |
Why?
| | Blotting, Western | 1 | 2013 | 1194 | 0.020 |
Why?
| | Substance-Related Disorders | 1 | 2019 | 971 | 0.020 |
Why?
| | Infant | 3 | 2008 | 8293 | 0.020 |
Why?
| | Neoplasm Staging | 1 | 2013 | 1223 | 0.020 |
Why?
| | Incidence | 1 | 2016 | 2424 | 0.020 |
Why?
| | Septal Occluder Device | 1 | 2010 | 47 | 0.020 |
Why?
| | Immunohistochemistry | 1 | 2013 | 1691 | 0.020 |
Why?
| | Tricuspid Atresia | 1 | 2008 | 7 | 0.020 |
Why?
| | Venae Cavae | 1 | 2008 | 10 | 0.020 |
Why?
| | Contrast Media | 1 | 2011 | 373 | 0.020 |
Why?
| | Vena Cava, Superior | 1 | 2008 | 21 | 0.020 |
Why?
| | Pilot Projects | 1 | 2013 | 1419 | 0.020 |
Why?
| | Anastomosis, Surgical | 1 | 2008 | 146 | 0.020 |
Why?
| | Oxygen Consumption | 1 | 2011 | 586 | 0.020 |
Why?
| | Linear Models | 1 | 2010 | 827 | 0.020 |
Why?
| | Treatment Failure | 1 | 2008 | 341 | 0.020 |
Why?
| | Biomarkers, Tumor | 1 | 2013 | 1059 | 0.020 |
Why?
| | Gene Expression Profiling | 1 | 2013 | 1597 | 0.020 |
Why?
| | Cell Line, Tumor | 1 | 2013 | 2851 | 0.020 |
Why?
| | Patient Selection | 1 | 2010 | 675 | 0.020 |
Why?
| | Prostatic Neoplasms | 1 | 2013 | 940 | 0.020 |
Why?
| | Pulmonary Circulation | 1 | 2008 | 424 | 0.020 |
Why?
| | Longitudinal Studies | 1 | 2013 | 2513 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2013 | 2874 | 0.020 |
Why?
| | Prognosis | 1 | 2013 | 3443 | 0.020 |
Why?
| | Health Services Needs and Demand | 1 | 2007 | 254 | 0.020 |
Why?
| | Quality of Life | 1 | 2016 | 2366 | 0.020 |
Why?
| | Length of Stay | 1 | 2008 | 1031 | 0.010 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2008 | 709 | 0.010 |
Why?
| | Magnetic Resonance Imaging | 1 | 2014 | 3174 | 0.010 |
Why?
| | Double-Blind Method | 1 | 2006 | 1687 | 0.010 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2006 | 1945 | 0.010 |
Why?
| | Surveys and Questionnaires | 1 | 2013 | 4708 | 0.010 |
Why?
| | Pregnancy | 1 | 2011 | 5691 | 0.010 |
Why?
| | Body Mass Index | 1 | 2006 | 2092 | 0.010 |
Why?
| | Clinical Trials as Topic | 1 | 2003 | 968 | 0.010 |
Why?
| | Infant, Newborn | 1 | 2008 | 5255 | 0.010 |
Why?
|
|
Kay's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|